SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006422
Filing Date
2017-08-09
Accepted
2017-08-09 16:13:10
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20170630x10q.htm 10-Q 1890801
2 EX-31.1 edit-20170630ex3118486e5.htm EX-31.1 19711
3 EX-31.2 edit-20170630ex312a32935.htm EX-31.2 19271
4 EX-32.1 edit-20170630ex3211624ee.htm EX-32.1 13558
  Complete submission text file 0001558370-17-006422.txt   6329687

Data Files

Seq Description Document Type Size
5 EX-101.INS edit-20170630.xml EX-101.INS 1200417
6 EX-101.SCH edit-20170630.xsd EX-101.SCH 52122
7 EX-101.CAL edit-20170630_cal.xml EX-101.CAL 40727
8 EX-101.DEF edit-20170630_def.xml EX-101.DEF 176004
9 EX-101.LAB edit-20170630_lab.xml EX-101.LAB 442450
10 EX-101.PRE edit-20170630_pre.xml EX-101.PRE 308104
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 171018015
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences